Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and clinical effect of re-exposure to a 24
week course of treatment of pegloticase i.v. in subjects whose last exposure to pegloticase
i.v. was at least one year before study entry.
This study is limited to four study centers in the US.